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because we included samples from 




genetic analysis of amplicons from 
PCR and nested PCR indicated that 
samples were positive for HKU1 
genotype B (samples BRA169, 
BRA90, and BRA99) or HKU1 
genotype A (samples BRA09, BRA37, 
and BRA104). The sequences obtained 
in this study have been deposited 
in GenBank under accession nos. 
FJ931534.1 (BRA169), GU904424 
(BRA37), GU904427 (BRA104), 
GU904423 (BRA09), GU904425 
(BRA90), and GU904426 (BRA99).
This may be the oldest collection 
of human samples in which HKU1 
has been detected. To our knowledge, 
the oldest previous sample positive 
for HCoV-HKU1 was detected in 
children in Finland during 1996–1998, 
without an exact date specifi ed (7). 
Retrospective studies also have been 
conducted in the United States and 
Greece that showed the HKU1 virus 
in different countries in Europe and 
North America before its discovery 
(8,9). We have confi rmed the 
circulation of HKU1 coronaviruses in 
children in Brazil in 1995.
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To the Editor: Mycoplasma 
genitalium is now recognized as 
a serious pathogen in sexually 
transmitted infections (1,2). 
Azithromycin regimens have been 
commonly used for treatment of M. 
genitalium infections (3). However, 
failure of azithromycin treatment 
has been reported in cases of M. 
genitalium–positive nongonococcal 
urethritis (NGU) (4,5), and macrolide-
resistant strains of M. genitalium 
have been isolated from case-patients 
in Australia, Sweden, and Norway 
for whom azithromycin treatment 
has failed (4,5). In these strains, 
mutations in the 23S rRNA gene were 
associated with macrolide resistance, 
and mutations in ribosomal protein 
genes L4 and L22 were also found 
(5). Surveillance for antimicrobial 
resistance of M. genitalium is 
essential to identify antimicrobial 
resistant strains and to then determine 
appropriate treatment. Coculture of 
patient specimens with Vero cells 
has improved the primary isolation 
rate of M. genitalium from clinical 
specimens and offered some current 
clinical strains for antimicrobial drug 
susceptibility testing (6). To determine 
their antimicrobial susceptibilities, 
a molecular real-time PCR method 
has been developed (7,8). However, 
isolating M. genitalium from clinical 
specimens and antimicrobial drug 
susceptibility testing of clinical 
isolates remain labor-intensive, 
time-consuming tasks. In addition, 
no methods are available to directly 
determine antimicrobial drug 
susceptibilities of M. genitalium 
in clinical specimens. To monitor 
macrolide susceptibilities in clinical 
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strains of M. genitalium in Japan, 
therefore, we examined M. genitalium 
DNA found in the urine of men with 
NGU for the presence of macrolide 
resistance–associated mutations in 
the 23S rRNA gene and the ribosomal 
protein genes L4 and L22.
This retrospective study was 
approved by the Institutional Review 
Board of the Graduate School of 
Medicine, Gifu University, Gifu, 
Japan. We collected pretreatment 
urine specimens from 308 men with 
NGU who had visited a urologic clinic 
(iClinic) in Sendai, Japan, during 
2006 through 2008 and stored the 
specimens at –70°C. Each man gave 
informed consent. Twenty-fi ve of 
58 urine specimens confi rmed to be 
positive for M. genitalium by PCR-
based assay were randomly chosen 
for this study and subjected to DNA 
purifi cation. The 23S rRNA gene 
and the ribosomal proteins genes 
L4 and L22 of M. genitalium were 
amplifi ed from the purifi ed DNA by 
PCR as reported previously and then 
sequenced (5).
In 1 specimen, we found an A-to-G 
transition at nucleotide position 
2072 in the 23S rRNA gene of M. 
genitalium, corresponding to position 
2059 in Escherichia coli (Table). An 
A2059 (E. coli numbering) residue 
in region V of the 23S rRNA gene is 
critical for the binding of macrolides 
(9). Mutations of A2058, A2059, and 
other 23S rRNA residues within the 
macrolide-binding site can confer a 
high-level resistance to macrolides in 
several bacterial species, including 
M. genitalium (5,9). Therefore, M. 
genitalium strains that harbor the 
A2059G (E. coli numbering) mutation 
in the 23S rRNA gene could be highly 
macrolide resistant. We also found a 
T-to-G transition at nucleotide position 
2199 in the 23S rRNA gene of M. 
genitalium, corresponding to position 
2185 in E. coli, in 3 specimens, but 
this mutation has not been associated 
with macrolide resistance in other 
bacterial species (9).
We found amino acid changes in 
L4 and L22 ribosomal proteins in M. 
genitalium in 9 specimens. L4 and 
L22 ribosomal proteins each have 
extended loops, which converge to 
form a narrowing in the exit tunnel 
adjacent to the macrolide-binding site 
(10). Therefore, macrolide resistance–
associated missense mutations in 
L4 and L22 tend to be localized 
to Gln62–Gly66 in L4 and Arg88-
Ala93 in L22 of E. coli, which are 
closest to the macrolide-binding site 
(10). All of the amino acid changes 
in L4 of M. genitalium found in this 
study corresponded to those at the 
downstream regions from Gln62-
Gly66 in L4 of E. coli. Of the amino 
acid changes in L22 of M. genitalium, 
the only Gly93Glu change found in 
M. genitalium harboring the A2059G 
(E. coli numbering) mutation in the 
23S rRNA gene was located within 
the region corresponding to Arg88-
Ala93 in L22 of E. coli. In this strain, 
therefore, the Gly93Glu change in L22 
might contribute to the increase of 
macrolide resistance. The patient with 
NGU, whose specimen exhibited this 
strain of M. genitalium that harbored 
both the A2059G (E. coli numbering) 
mutation in the 23S rRNA gene and in 
which the Gly93Glu change in L22 was 
detected, was given a single dose of 1 g 
azithromycin and was clinically cured 
of NGU. However, the present study 
suggests that M. genitalium strains 
with high-level macrolide resistance 
might have already emerged in clinical 
settings in Japan. The emergence and 
spread of such a clinical mutant could 
threaten the ability of macrolides to 
treat M. genitalium infections. We 
should continue monitoring macrolide 
resistance of M. genitalium clinical 
strains. The nonculture approach 
used in our study will be useful until 
culturing of mycoplasmas from 
clinical specimens and antimicrobial 
drug susceptibility testing can be 
performed easily in laboratories.
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Table. Mutations in the 23S rRNA gene and amino acid changes in L4 and L22 
ribosomal proteins of 25 Mycoplasma genitalium strains in the pretreatment urine 
specimens of men with nongonococcal urethritis, Japan 
No. urine 
specimens
Mutation in the 23S 
rRNA gene* 
Amino acid change 
L4 L22
1 A2059G – Gly93Glu/Asp109Glu 
1 T2185G Val84Gly –
1 T2185G GLu128Gly –
2 T2185G – –
1 – Pro81Ser –
1 – Tyr135Pro –
1 – – Ser81Thr 
1 – – Met82Lys 
1 – – Asn112Asp
1 – – Arg114Lys 
14 – – –
*Nucleotide position in the 23S rRNA gene is according to Escherichia coli numbering. –, identical to 
the type strain. 
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To the Editor: Cardioviruses 
currently consist of at least 3 viruses: 
Theiler murine encephalomyocarditis 
virus, encephalomyocarditis virus, 
and Saffold virus (SAFV) (1–4). 
Saffold cardiovirus in the family 
Picornaviridae was isolated and 
identifi ed from fecal specimens of a 
child with fever of unknown origin in 
the United States (3).
Several reports have documented 
the presence of SAFV in fecal 
samples and respiratory secretions 
(5–10). However, it is not clear 
whether SAFV is associated with 
any disease, including gastroenteritis 
in humans, and epidemiologic data 
for SAFV are limited. We report an 
epidemiologic survey of SAFV in 
children hospitalized with diarrhea in 
Chiang Mai, Thailand.
A total of 150 fecal specimens 
were obtained from children 
hospitalized with acute gastroenteritis 
in Chiang Mai during January–
December 2007. Patient ages ranged 
from >1 to 5 years. SAFV in fecal 
specimens was detected by using a 
nested PCR and primers specifi c for 
the virus 5′ untranslated region (7). A 
negative control was also included to 
monitor any contamination that might 
have occurred during the PCR.
SAFVs detected were further 
analyzed by amplifi cation of the 
viral protein (VP) 1 gene (6,9,10) 
and direct sequencing of the VP1 
PCR amplicon by using the BigDye 
Terminator Cycle Sequencing Kit 
(Applied Biosystems, Foster City, CA, 
USA). VP1 sequence was compared 
with VP1 sequences of reference 
strains available in the National 
Center for Biotechnology Information 
(Bethesda, MD, USA). Phylogenetic 
and molecular evolutionary analyses 
were conducted by using MEGA4 
(www.megasoftware.net). Nucleotide 
sequences of SAFV strains described 
were deposited in GenBank 
under accession nos. HQ668170–
HQ668173.
Four (2.7%) of 150 specimens 
were positive for SAFV 
(CMH023/2007, CMH038/2007, 
CMH045/2007, and CMH143/2007). 
Two of these specimens 
(CMH023/2007 and CMH038/2007) 
were obtained in February 2007, one 
(CMH045/2007) in March 2007, 
and 1 (CMH143/2007) in November 
2007. Co-infections with other 
viruses were detected in all 4 samples. 
Two specimens (CMH023/2007and 
CMH045/2007), were co-infected 
with noroviruses GII/16 and GII/4 
genotypes, respectively. One SAFV-
positive sample (CMH038/2007) was 
co-infected with a group A rotavirus 
G1P[8] genotype, and another 
(CMH143/2007) was co-infected with 
human parechovirus.
All SAFV-positive specimens 
were further amplifi ed for the VP1 
gene to determine their phylogenetic 
lineages and genetic relationships with 
other SAFV reference strains. When 
we used 3 sets of primers used in other 
studies (6,9,10) for amplifi cation of 
the VP1 gene, this gene was amplifi ed 
only by the primer set reported by 
Itagaki et al. (10).
Analysis of partial VP1 
sequences (369 nt) of 4 SAFV strains 
showed that strains CMH023/2007 
and CMH143/2007 were highly 
conserved (nt sequence identities 
>97%). These 2 SAFV strains were 
most closely related to the prototype 
strain of SAFV1 (EF165067) isolated 
in the United States (nt sequence 
identity range 87.6%–88.9%) and 
SAFV strains from China (LZ50419, 
BCH895, GL311, and GL377) 
(Figure). In addition, the other 2 
SAFVs identifi ed in the present study 
(CMH038/2007 and CMH045/2007) 
were identical to each other and 
closely related to SAFV2 strains 
from China (BCHU79, BCHU353) 
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